- LNA drug platform
- drug discovery engine
- mechanism of action
- intellectual property
- scientific publications
Santaris Pharma A/S® is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris combine our proprietary LNA chemistry with highly specialized and targeted drug development capabilities to rapidly deliver potent, single-stranded LNA-based drug candidates across a multitude of disease states.
Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.
If you are interested in job opportunities and would like to play a role in an exciting company with an enormous potential, please send a job application to firstname.lastname@example.org or to:
Santaris Pharma A/S
c/o Bo Ritsmar
Corporate Project & HSE Manager
DK 2970 Hørsholm